Evidence map›Paper›PMID 31043716›Full record

ArticleNature reviews. Urology2019

Publisher Correction: The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocol.

Gordan M Vujanić, Manfred Gessler, Ariadne H A G Ooms, Paola Collini, Aurore Coulomb-l'Hermine, Ellen D'Hooghe, Ronald R de Krijger, Daniela Perotti, Kathy Pritchard-Jones, Christian Vokuhl and 3 more

Abstract readPublished Erratum
In one paragraph

Article in Nature reviews. Urology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Gordan M VujanićDepartment of Pathology, Sidra Medicine, Doha, Qatar. gvujanic@sidra.org.
Manfred GesslerTheodor- Boveri-Institute/Biocenter, Developmental Biochemistry, Wuerzburg University, Wuerzburg, Germany.ORCID http://orcid.org/0000-0002-7915-6045
Ariadne H A G OomsPrincess Maxima Centre for Pediatric Oncology, Utrecht, Netherlands.
Paola ColliniDepartment of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Aurore Coulomb-l'HermineSorbonne Université, Department of Pathology, Hopitaux Universitaires Est Parisien, Paris, France.
Ellen D'HoogheDepartment of Pathology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Ronald R de KrijgerPrincess Maxima Centre for Pediatric Oncology, Utrecht, Netherlands.
Daniela PerottiMolecular Bases of Genetic Risk and Genetic Testing Unit, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Kathy Pritchard-JonesGreat Ormond Street Institute of Child Health, University College London, London, UK.ORCID http://orcid.org/0000-0002-2384-9475
Christian VokuhlKiel Paediatric Tumour Registry, Department of Paediatric Pathology, University Hospital of Kiel, Kiel, Germany.
Marry M van den Heuvel-EibrinkPrincess Maxima Centre for Pediatric Oncology, Utrecht, Netherlands.
Norbert GrafDepartment of Paediatric Oncology & Haematology, Saarland University, Homburg, Germany.ORCID http://orcid.org/0000-0002-2248-323X
International Society of Paediatric Oncology–Renal Tumour Study Group (SIOP–RTSG)

Funding

Cancer Research UK 17297
6 · The paper itself

Abstract

In the version of this article initially published online it was not open access, this has now been corrected.

Identifiers

PMID31043716
PMCPMC7608427

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.